Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/19706799

Clin. Cancer Res. 2009 Sep 1 15 17 5445-56

Download in:

View as

Triples

General Info

PMID
19706799